CPAP/PSV Preoxygenation in Obese Patients
Primary Purpose
Obesity, Anaesthesia
Status
Completed
Phase
Not Applicable
Locations
Sweden
Study Type
Interventional
Intervention
CPAP 5 cm H2O + PSV 5 cm H2O
Sponsored by

About this trial
This is an interventional prevention trial for Obesity focused on measuring Obesity, general anaesthesia, preoxygenation, atelectasis
Eligibility Criteria
Inclusion Criteria:
- body mass index (BMI) > 35 kg/m2
- scheduled to undergo elective gastric bypass surgery
- age ≥ 18 years
- ASA Physical Status Classification II-III
Exclusion Criteria:
- significant cardiopulmonary disease
- previous abdominal or thoracic surgery
- inability to comprehend the protocol.
Sites / Locations
- Department of Anesthesiology and Intensive Care Danderyd Hospital
Arms of the Study
Arm 1
Arm 2
Arm Type
No Intervention
Active Comparator
Arm Label
Control group
Active group
Arm Description
Neutral pressure breathing after 2 min preoxygenation
CPAP 5cm H2O + PSV 5cm H2O breathing after 2 min preoxygenation
Outcomes
Primary Outcome Measures
Post intubation PaO2levels
PaO2 levels is measured within 5 minutes after the completion of intubation.
Secondary Outcome Measures
Full Information
NCT ID
NCT01780571
First Posted
December 9, 2012
Last Updated
January 29, 2013
Sponsor
Karolinska Institutet
1. Study Identification
Unique Protocol Identification Number
NCT01780571
Brief Title
CPAP/PSV Preoxygenation in Obese Patients
Official Title
Continuous Positive Airway Pressure/Pressure Support Preoxygenation of Morbidly Obese Patients
Study Type
Interventional
2. Study Status
Record Verification Date
January 2013
Overall Recruitment Status
Completed
Study Start Date
May 2009 (undefined)
Primary Completion Date
June 2012 (Actual)
Study Completion Date
December 2012 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Karolinska Institutet
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The purpose of this study is to determine whether continuouse positive airway pressure (CPAP), during induction of anaesthesia in morbidly obese patients, result in higher levels of oxygen in the blood.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Obesity, Anaesthesia
Keywords
Obesity, general anaesthesia, preoxygenation, atelectasis
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
44 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Control group
Arm Type
No Intervention
Arm Description
Neutral pressure breathing after 2 min preoxygenation
Arm Title
Active group
Arm Type
Active Comparator
Arm Description
CPAP 5cm H2O + PSV 5cm H2O breathing after 2 min preoxygenation
Intervention Type
Procedure
Intervention Name(s)
CPAP 5 cm H2O + PSV 5 cm H2O
Intervention Description
Patients in the intervention group received Continuous Positive Airway Pressure (5 cm H2O) and Pressure Supported Ventilation (5 cm H2O)
Primary Outcome Measure Information:
Title
Post intubation PaO2levels
Description
PaO2 levels is measured within 5 minutes after the completion of intubation.
Time Frame
5 minutes after intubation
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
body mass index (BMI) > 35 kg/m2
scheduled to undergo elective gastric bypass surgery
age ≥ 18 years
ASA Physical Status Classification II-III
Exclusion Criteria:
significant cardiopulmonary disease
previous abdominal or thoracic surgery
inability to comprehend the protocol.
Facility Information:
Facility Name
Department of Anesthesiology and Intensive Care Danderyd Hospital
City
Stockholm
ZIP/Postal Code
18288
Country
Sweden
12. IPD Sharing Statement
Learn more about this trial
CPAP/PSV Preoxygenation in Obese Patients
We'll reach out to this number within 24 hrs